<?xml version="1.0" encoding="UTF-8"?>
<ref id="B77-ijms-22-00634">
 <label>77.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Miyake</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Nishimura</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kato</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ikeda</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Tsujie</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hata</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Takemasa</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Mizushima</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sekimoto</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG)</article-title>
  <source>Surg. Today</source>
  <year>2018</year>
  <volume>48</volume>
  <fpage>66</fpage>
  <lpage>72</lpage>
  <pub-id pub-id-type="doi">10.1007/s00595-017-1555-1</pub-id>
  <pub-id pub-id-type="pmid">28634730</pub-id>
 </element-citation>
</ref>
